Role of ERK-MAPK signaling pathway in pentagastrin-regulated growth of large intestinal carcinoma

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 20, Issue 35

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

461

WORD

205

HTML

3790

Figures (1-4)

202

Tables (1-5)

164

Sum=4822

Sep 21, 2014 (publication date) through Dec 2, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Original Article

World J Gastroenterol. Sep 21, 2014; 20(35): 12542-12550
Published online Sep 21, 2014. doi: 10.3748/wjg.v20.i35.12542

Table 4 Comparison of proliferation index and apoptotic rates between the experimental groups and control group (mean ± SD)

Group	n	PI			AR
Group	n	PI (%)	F	P value	AR (%)	F	P value
Control group	5	27.72 ± 5.00			2.53 ± 0.36
Pentagastrin group	5	37.54 ± 5.17^a	7.59	0.01	1.91 ± 0.42^a	6.50	0.01
Proglumide group	5	27.36 ± 2.68^c			2.79 ± 0.45^c
Pentagastrin + proglumide group	5	27.31 ± 5.76^c			2.41 ± 0.30^c

^aP < 0.05 vs control group;

^cP < 0.05 vs pentagastrin group. AR: Apoptosis rate; PI: Proliferation index.

Citation: Mao JD, Wu P, Huang JX, Wu J, Yang G. Role of ERK-MAPK signaling pathway in pentagastrin-regulated growth of large intestinal carcinoma. World J Gastroenterol 2014; 20(35): 12542-12550
URL: https://www.wjgnet.com/1007-9327/full/v20/i35/12542.htm
DOI: https://dx.doi.org/10.3748/wjg.v20.i35.12542